Trademark: 79008059
Word
SANOVEL
Status
Dead
Status Code
404
Status Date
Wednesday, May 12, 2021
Serial Number
79008059
Registration Number
3154206
Registration Date
Tuesday, October 10, 2006
Mark Type
4000
Filing Date
Monday, September 13, 2004
Published for Opposition
Tuesday, January 24, 2006
Cancellation Date
Wednesday, May 12, 2021

Trademark Owner History

Classifications
5 PHARMACEUTICAL PREPARATIONS FOR THE TREATMENT OF CARDIOVASCULAR DISORDERS, SKELETO-MUSCULAR DISORDERS, GENERAL INFECTIONS, VIRAL INFECTIONS, CENTRAL NERVOUS SYSTEM DISORDERS, GASTRO-INTESTINAL DISORDERS, FUNGAL DISEASES, ERECTILE DYSFUNCTION, RESPIRATORY DISEASES, ALLERGY, OPHTHALMIC DISEASES, CONTAINING ONE OR MORE OF THE FOLLOWING ACTIVE INGREDIENTS - CROMOLIN SODIUM, AMLODIPIN BESYLATE, ALENDRONATE SODIUM, CHLORAZEPATE DIPOTASSIUM, ATROPINE SULPHATE, ATORVASTATIN CALCIUM, CANDESARTAN CILEXETIL, CEFTRIAXONE SODIUM, EPHEDRINE HCL, GUAIPHENESINE, ZAFIRLUKAST, DONEPEZIL HCL, DIFLUNISAL, DIPYRIDAMOLE, FAMOTIDINE, LOSARTAN POTASSIUM, HYDRO-CHLOROTHIAZIDE, MELOXICAM, PHENYLEPRINE HCL, FEXOFENADINE HCL, INDAPAMIDE, SULFISOXAZOLE, CLOPIDOGREL, LANSOPRAZOLE, CLARITHROMYCIN, FLURBIPROFEN, NIMESULIDE, PANTOPRAZOLE, PARACETAMOLE, PILOCARPINE HCL, LISINOPRIL, PSEUDOEPHEDRINE HCL, CIPROFLOXACIN HCL, SERTRALINE HCL, CYCLOPENTOLATE HCL, DIHYDROERGOTOXINE METHANSULFONATE, TERBINAFINE, TIMOLOL MALEATE, TIAMPHENICOL, AZITHROMYCIN, TENOXICAM, FLUCONAZOLE, DIGOXINE, TIOCONAZOLE, DIMENHYDRINATE, QUINIDINE ARABOGALACTANE SULPHATE, QUINIDINE PHENYLETHYL BARBITURATE, DILTIAZEM HCL, BUSPIRONE HCL, AMIODARONE HCL, TRAZODONE, DIFLUPREDNATE, ENOXACIN, LACTULOSE, KETOROLAC, PENTOXIFYLLINE, VITAMIN E, CHLORHEXIDINE, CETRIMIDE, PROPYPHENAZONE, CAFFEINE, CETIRIZINE, PHENYLPROPANOLAMINE, ZOLPIDEM, BACAMPICILLIN HCL, ROXITHROMYCIN, SULTAMICILLIN TOSILATE, ACETYLSALICYLIC ACID, AMPICILLIN NA, SULBACTAM NA, SILDENAFIL CITRATE, AMBROXOL HCL, RIBAVIRIN, LORATADINE, ETODOLAC, OMEPRAZOLE, OXYBUTYNIN CHLORIDE, QUINIDINE SULPHATE, OLANZAPINE, RALOXIFEN, PIOGLITAZONE, MOXIFLOXACIN, ROSIGLITAZONE, SIBUTRAMIN, CARVEDILOL, MONTELUKAST, CITALOPRAM, GLICLAZIDE, CEFACLOR, EZETIMIBE, ROFECOXIB, QUETIAPINE FUMARATE, METFORMIN HCL, ACARBOSE, CHLORPHENIRAMINE MALEATE, NATEGLINIDE, LEFLUNOMIDE, VALSARTAN, CEFAZOLIN SODIUM, DIACEREIN, PAROXETINE, LEVOFLOXACIN, LEVETIRACETAM, ZOLMITRIPTAN, GLIBENCLAMIDE, TIZANIDINE, PERINDOPRIL ERBUMINE, RAMIPRIL, CEFTAZIDIME, CEFUROXIME AXETYL, THIOCOLCHICOSIDE, ACAMPROSATE, ACETYLCYSTEINE, ALPHA CALCIDOL, ALPHA LIPOIC ACID, ARIPIPRAZOLE, ATOMOXETINE, BALSALAZIDE DISODIUM, BUTENAFINE HCL, CALCITRIOL, CARBONYL IRON, FOLIC ACID, CALCIUM CARBONATE, MAGNESIUM HYDROXIDE, CEFDINIR, CEFEPIME HCL, CEFIXIME, CEFPODOXIME PROXETIL, CEFPROZIL, CEPHALEXINE MONOHYDRATE, CICLESONIDE, CILAZAPRIL, CILOSTAZOL, CINITAPRIDE, CITICOLINE, CO-ENZYME Q10, DARIFENASIN, DEFERIPRONE, DOTHIEPIN, DULOXETINE, ELETRIPTAN, ESCITALOPRAM, ESOMEPRAZOLE, ETORICOXIB, FELODIPINE, FENOFIBRATE, FERROUS SULPHATE, ZINC SULPHATE, FLUVASTATIN, FROVATRIPTAN, GABAPENTIN, GALANTAMINE, GEMIFLOXACIN, GINKGO BILOBA, GLIMEPRIDE, GRANISETRON, IBANDRONATE, IRBESARTAN, IRON HYDROXIDE POLYMALTOSE, LAMIVUDINE, LAMOTRIGINE, LEVETIRACETAM, LETROZOLE, LINEZOLIDE, MEMANTINE HCL, METOPROLOL, MIDODRINE, MIRTAZAPINE, MIZOLASTINE, MOSAPRIDE CITRATE DIHYDRATE, MYCOPHENOLATE MOFETIL, NEBIVOLOL, NEFAZODONE, NIACIN, NITAZOXANIDE, ONDANSETRON, ORNIDAZOLE, OXCARBAZEPINE, PIMECROLIMUS, PRAVASTATIN, PREGABALIN, RABEPRAZOL, REBAMIPIDE, REPAGLINIDE, RISEDRONATE, RISPERIDONE, RIVASTIGMINE, ROSUVASTATIN, SACCHAROMYCES BOULARDII, TACROLIMUS, TADALAFIL, TAMSULOSIN HCL, TAZAROTEN, TAZOBACTAM SODIUM, PIPERACILLIN SODIUM, TEGASEROD, TELITHROMYCIN, TERAZOCIN, TERIPARATIDE, TOLTERODINE TARTRATE, TOPIRAMATE, TRANDOLAPRIL, TRIMETHAZIDINE, VALACYCLOVIR, VALPROATE SODIUM, VENLAFAXINE, VORICONAZOLE, XIMELAGATRAN, ZALEPLON, ZIPRASIDONE, ZOLEDRONIC ACID

Trademark Events
Nov 28, 2021
Notification Of Effect Of Cancellation Of Intl Reg Mailed
Nov 28, 2021
Death Of International Registration
Jan 25, 2018
New Representative At Ib Received
Jun 1, 2015
Total Invalidation Processed By The Ib
Aug 27, 2014
Generic Madrid Transaction Sent To Ib
Aug 27, 2014
Generic Madrid Transaction Created
May 13, 2014
Total Invalidation Of Reg Ext Protection Created
Sep 13, 2013
Cancelled Section 71
Nov 3, 2012
Change Of Name/Address Rec'd From Ib
Jun 2, 2011
International Registration Renewed
Jun 5, 2008
Final Decision Transaction Processed By Ib
May 7, 2007
Final Disposition Notice Sent To Ib
May 7, 2007
Final Disposition Processed
May 7, 2007
Final Disposition Notice Created, To Be Sent To Ib
Oct 10, 2006
Registered-Principal Register
Aug 3, 2006
Notification Of Possible Opposition - Processed By Ib
Jul 20, 2006
Notification Of Possible Opposition Sent To Ib
Jul 20, 2006
Notification Of Possible Opposition Created, To Be Sent To Ib
Jul 14, 2006
Teas Change Of Correspondence Received
Jun 9, 2006
Extension Of Time To Oppose Process - Terminated
Feb 21, 2006
Extension Of Time To Oppose Received
Jan 24, 2006
Published For Opposition
Jan 4, 2006
Notice Of Publication
Dec 7, 2005
Law Office Publication Review Completed
Dec 2, 2005
Assigned To Lie
Nov 28, 2005
Approved For Pub - Principal Register
Oct 27, 2005
Amendment From Applicant Entered
Oct 14, 2005
Correspondence Received In Law Office
Oct 14, 2005
Paper Received
Jun 20, 2005
Refusal Processed By Ib
Apr 14, 2005
Non-Final Action Mailed
Apr 11, 2005
Non-Final Action Written
Apr 11, 2005
Assigned To Examiner
Feb 18, 2005
New Application Entered In Tram
Feb 17, 2005
Sn Assigned For Sect 66a Subseq Desig From Ib

Trademark Alertz updated from USPTO on 2030-01-24